secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0001104659-24-090567
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents appoints Peter J. Mariani as CFO; Kathleen P. Bloch retires
------------------------------------------------------------------------

- Peter J. Mariani appointed CFO effective Aug 14, 2024; previously CFO of Axogen (2016-2023).
- Mariani receives base salary of $425,000, cash bonus up to 45%, and inducement awards of stock options & RSUs.
- Kathleen P. Bloch retired as CFO and will serve as consultant at $335/hour through Dec 31, 2025.
- CEO highlights Mariani's experience as company pursues U.S. FDA/Health Canada approval for DrugSorb-ATR.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465924090567/0001104659-24-090567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465924090567/tm2421901d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-090567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer